Want to retire wealthy? I’d buy these 2 FTSE 100 dividend shares for a rising passive income

These two FTSE 100 (INDEXFTSE:UKX) stocks have the pedigree to deliver long-term dividend income growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Who doesn’t want to retire wealthy? Spending your later years free of financial worries, and making the most of all that free time, is a universal dream.

I think the best way to achieve it is to invest in a portfolio of stocks and shares, using your tax-free Stocks and Shares ISA. I’d suggest looking at these two top FTSE 100 dividend and growth stocks.

AstraZeneca

The AstraZeneca (LSE: AZN) share price has been flying lately, up 25% over the last year, and 75% over five years. This is a tribute to CEO Pascal Soriot, who has worked hard to turn the company around since joining in 2012. Investors were concerned that the pharmaceutical giant’s pipeline of new drugs was running dry, at the same time as several blockbuster treatments came off patent, allowing generic competitors to pile in to its patch.

Soriot responded by pouring money into R&D and it is starting to pay off, as the group gets regulatory approval for a number of new medicines.

AstraZeneca has raised its sales guidance twice in the last year, with full-year product sales up 12% to a hefty $23.6bn, while sales of new medicines rose 59% to $9.9bn. While the coronavirus could hit Chinese earnings, recent strong performance gives it a cushion.

Another concern is that the US Presidential election could whip up public anger over drugs pricing. However, in the longer run, our ageing society will need all the pharmaceuticals it can get, and AstraZeneca is in a good place right now. The stock currently yields just 2.8%, but that partly reflects strong recent share price growth, and you can expect dividends to rise steadily over time. AstraZeneca stock isn’t cheap, trading at 24.2 times forward earnings, but that’s because it is a quality stock.

BAE Systems

The BAE Systems (LSE: BA) share price has climbed an impressive 43% over the past 12 months, re-establishing its reputation as one of the top FTSE 100 stocks around.

Its recent full-year results also impressed, with sales up 7% to £20.1bn, and operating business cash flow up more than 30% to £1.3bn. Crucially for income investors, dividends totalled 23.2p per share for the year, up 4.5% compared to last year. This kind of growth is vital, because it means payouts are growing faster than inflation, which gives you a rising passive income from your portfolio.

One concern is its large pension deficit, but it is taking advantage of low interest rates to fund £1bn of accelerated pension deficit funding.

Despite the surge in BAE Systems stock, the shares still only trade at 13.8 times earnings, which makes now look like an attractive entry point to me. The forecast yield of 3.6% is covered twice by earnings, and as we have seen, looks set to rise much faster than inflation.

Top FTSE 100 dividend growth stocks like these two are exactly what you need to generate the rising passive income that can help you get the most out of life during your retirement.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How much passive income will I get from investing £10,000 in an ISA for 10 years?

Harvey Jones shows how he plans to boost the amount of passive income he gets when he retires, from FTSE…

Read more »

Investing Articles

Down 34% in 2025 — but could this be one of the UK’s top growth stocks for 2026?

With clarity over research funding on the horizon, could Judges Scientific be one of the UK’s best growth stocks to…

Read more »

piggy bank, searching with binoculars
Investing Articles

Can the rampant Barclays share price beat Lloyds in 2026?

Harvey Jones says the Barclays share price was neck and neck with Lloyds over the last year, and checks out…

Read more »

Investing Articles

Here’s how Rolls-Royce shares could hit £25 in 2026

If Rolls-Royce shares continue their recent performance, then £25 might be on the cards for 2026. Let's take a look…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

Prediction: in 2026 the red-hot Rolls-Royce share price could turn £10,000 into…

Harvey Jones can't believe how rapidlly the Rolls-Royce share price has climbed. Now he looks at the FTSE 100 growth…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

Prediction: Tesco shares could soon climb another 17%

After a strong run for Tesco shares, analysts are optimistic for the start of 2026. Well, most of them are,…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

Prediction: the Vodafone share price could soar 40% in 2026

Despite a great 2025, the Vodafone share price is still down 20% over five years. The latest predictions suggest more…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

By January 2027, £1,000 invested in Nvidia shares could turn into…

What could £1,000 in Nvidia shares do by 2027? Our Foolish author explores three potential scenarios for the artificial intelligence…

Read more »